The rating assignment is based on a number of factors, including Legacy’s continued strong operating performance, maintenance of solid liquidity measures and gradual but steady market share growth.
The outlook is stable, reflecting Moody’s Investors Service’s expectation that Legacy’s operating performance measures will remain strong and that it can accomplish its capital plans without further dilution of its balance sheet.
More articles on healthcare finance:
RCM tip of the day: Create a single source of truth with data
4 healthcare CFOs in the headlines
CHS faces fraud allegations from investor in Quorum spin-off: 7 things to know
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
